Back
CureVac NV Vs. InflaRx NV Industry Stock Comparison
Buy
52
CVAC
CureVac NV
Last Price:
3.09
Seasonality Move:
-15.03%
Sell
23
IFRX
InflaRx NV
Last Price:
1.42
Seasonality Move:
-16.7%
Buy
52
CureVac NV (CVAC)
is a Buy
Is CureVac NV a Buy, Sell or Hold?
- The current CureVac NV [CVAC] share price is $2.97. The Score for CVAC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CVAC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
InflaRx NV (IFRX)
is a Sell
Is InflaRx NV a Buy, Sell or Hold?
- The current InflaRx NV [IFRX] share price is $1.25. The Score for IFRX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- IFRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVAC Stock Price Chart
What is CureVac NV's stock price today?
-
The CureVac NV share price today is $2.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVAC is experiencing slight selling pressure.
IFRX Stock Price Chart
What is InflaRx NV's stock price today?
-
The InflaRx NV share price today is $1.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IFRX is experiencing slight selling pressure.
CVAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 55.25 | Buy |
| Chaikin Money Flow: | -16015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.49 - 2.97) | Buy |
| Bollinger Bands (100): | (2.84 - 3.82) | Sell |
IFRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 39.91 | Sell |
| Chaikin Money Flow: | -34861 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.25 - 1.47) | Sell |
| Bollinger Bands (100): | (1.4 - 1.72) | Sell |
CVAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.95 | Buy |
| 20-day SMA: | 2.68 | Buy |
| 50-day SMA: | 2.94 | Buy |
| 200-day SMA: | 5.12 | Sell |
| 8-day EMA: | 2.89 | Buy |
| 20-day EMA: | 2.82 | Buy |
| 50-day EMA: | 2.99 | Sell |
| 200-day EMA: | 4.95 | Sell |
IFRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.27 | Sell |
| 20-day SMA: | 1.32 | Sell |
| 50-day SMA: | 1.47 | Sell |
| 200-day SMA: | 2.08 | Sell |
| 8-day EMA: | 1.26 | Sell |
| 20-day EMA: | 1.33 | Sell |
| 50-day EMA: | 1.43 | Sell |
| 200-day EMA: | 1.97 | Sell |
CureVac NV Earnings Growth & CVAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.24 per share.
InflaRx NV Earnings Growth & IFRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.13 per share.
CureVac NV Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
InflaRx NV Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||